healthcare hub
Mubadala Bio aims to build UAE’s influence in pharma industry
The sovereign wealth fund's new unit will focus on drugmaking, biopharma development and logistics, with operations across Asia, Africa and Europe
Mubadala
Mubadala Bio's booth at the "Make it in the Emirates" conference in Abu Dhabi
Share 
Mubadala is consolidating its pharmaceutical interests into a new investment unit aimed at making the Abu Dhabi sovereign wealth fund a stronger player in the international health care market.
Mubadala Bio will focus on drugmaking, biopharma development and distribution...